Covid-19
WHO: New Covid-19 cases around the world dropped 16% last week
18 Feb, 2021 | 03:04h | UTCNew Covid-19 Cases Around The World Dropped 16% Last Week, World Health Organization Says – Forbes
The coronavirus is here to stay — here’s what that mean
17 Feb, 2021 | 01:44h | UTCThe coronavirus is here to stay — here’s what that means – Nature
Ocular MRI findings in patients with severe COVID-19
17 Feb, 2021 | 01:42h | UTCCommentaries: New COVID-19 side effect: MRI links severe infection to dangerous eye problems – Health Imaging AND MRI illuminates COVID-19’s negative impact on the eyes – AuntMinnie AND Windows of Infection: MRI Reveals COVID-19-Linked Eye Abnormalities – Diagnostic Imaging
Why more contagious variants are emerging now, more than a year into the COVID-19 pandemic
17 Feb, 2021 | 01:41h | UTC
Perspective: We can use the pandemic to reimagine global health teaching
17 Feb, 2021 | 01:39h | UTCWe Can Use The Pandemic To Reimagine Global Health Teaching – Forbes
Essay: Will we be ready for the next Pandemic?
17 Feb, 2021 | 01:36h | UTCWill We Be Ready for the Next Pandemic? – Wall Street Journal
Commentary on Twitter
The world will inevitably face another pandemic, and “the costs of preparedness will be dwarfed by the price of disaster,” writes former CDC chief Tom Frieden. https://t.co/xZNT82yArq via @WSJ
— Dr. Tom Frieden (@DrTomFrieden) February 13, 2021
Cohort study: Factors associated with severe SARS-CoV-2 infection in children
17 Feb, 2021 | 01:38h | UTCFactors Associated With Severe SARS-CoV-2 Infection – Pediatrics
Commentary: Large study outlines risk factors for severe COVID-19 in children – 2 Minute Medicine
Perspective: What science can and cannot do in a time of pandemic
17 Feb, 2021 | 01:34h | UTCWhat Science Can and Cannot Do in a Time of Pandemic – Scientific American
COVID-19: A Hematologist’s Perspective
17 Feb, 2021 | 01:35h | UTCCoronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective – Acta Haematologica
Editorial: A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?
Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest
17 Feb, 2021 | 01:32h | UTC
Commentary on Twitter
#COVID19 was involved in at least 10% of all out-of-hospital cardiac arrests (OHCA) and 16% of intra-hospital cardiac arrests (IHCA) and, among #COVID_19 cases, 30-day mortality was increased 3.4-fold in OHCA & 2.3-fold in IHCA https://t.co/uS6rzTXuew#EHJ #ESCYoung @ehj_ed pic.twitter.com/QisuU9rsLT
— European Society of Cardiology Journals (@ESC_Journals) February 5, 2021
Incidence rate and clinical impacts of arrhythmia following COVID-19: a systematic review and meta-analysis of 17,435 patients
17 Feb, 2021 | 01:31h | UTC
Report: Using face masks in the community – effectiveness in reducing transmission of COVID-19
16 Feb, 2021 | 02:24h | UTC
Commentary on Twitter
#JustPublished: Updated report on using #FaceMasks in the community.
It reviews accumulated evidence on the suitability of using face masks and their effectiveness in reducing #COVID19 transmission.
Full report ⬇️https://t.co/6vtwAAkgEB
— ECDC (@ECDC_EU) February 15, 2021
Should you mix and match COVID-19 vaccines? Scientists are seeking answers
16 Feb, 2021 | 02:18h | UTCShould you mix and match COVID-19 vaccines? Scientists are seeking answers – Science (a few articles per month are free)
See also: Could mixing COVID vaccines boost immune response? – Nature
Covid-19: Are cloth masks still effective? And other questions answered
16 Feb, 2021 | 02:22h | UTCCovid-19: Are cloth masks still effective? And other questions answered – The BMJ
Review: Diagnostics for SARS-CoV-2 infections
16 Feb, 2021 | 02:20h | UTCDiagnostics for SARS-CoV-2 infections – Nature Materials
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
16 Feb, 2021 | 02:15h | UTC
Commentaries on Twitter
Our @TheLancet #COVID19 Commission/TF publication. 1- More funds to COVAX urgently needed 2- Support members of DCVMN to produce low-cost vaccines at scale 3- Support waiver of TRIPS to facilitate rapid scale-up of production and distribution @PeterHotezhttps://t.co/E8tYj69MBG
— Maria Elena Bottazzi (@mebottazzi) February 13, 2021
“The Lancet COVID-19 Commission supports the emergency waiver of TRIPS in all circumstances that would facilitate the rapid scale-up of production and distribution of life-saving COVID-19 vaccines and therapeutics..”https://t.co/e5FBqY9r2R
— Tahir Amin (@realtahiramin) February 14, 2021
Escaping Catch-22 — Overcoming Covid Vaccine Hesitancy
16 Feb, 2021 | 02:12h | UTCEscaping Catch-22 — Overcoming Covid Vaccine Hesitancy – New England Journal of Medicine
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
16 Feb, 2021 | 02:10h | UTC
Commentary on Twitter
RCTs Save Live$
DEXA saves live$
Potential health&economic impacts of dexamethasone treatment for #COVID19 patients
The study estimate that between July & Dec 2020, for ??, ~12,000 lives could be saved & ~650,000 lives saved globally over the same time https://t.co/B7jVa5Xc0s pic.twitter.com/mI0wPVUj4C— Antibiotic Steward? Bassam Ghanem (@ABsteward) February 10, 2021
SARS-CoV-2 variants and ending the COVID-19 pandemic
16 Feb, 2021 | 02:17h | UTCSARS-CoV-2 variants and ending the COVID-19 pandemic – The Lancet
Commentary on Twitter
2021 will be the year of the #COVID19 variant. A commentary in press in the @TheLancet discusses the issue and makes proposals on how to tackle it. The whole world will need to work together to get over this one. https://t.co/5Z6uNW7vBF pic.twitter.com/bnkYkmOtYm
— Michael Makris (@ProfMakris) February 12, 2021
Opinion: RECOVERY confirms benefit of tocilizumab combined with dexamethasone
16 Feb, 2021 | 02:09h | UTCPulmCrit – RECOVERY confirms benefit of toci combined with dexamethasone
Original study: RCT: Tocilizumab reduces deaths in patients hospitalized with COVID-19 (study and commentaries)
Covid-19: Is Manaus the final nail in the coffin for natural herd immunity?
16 Feb, 2021 | 02:07h | UTCCovid-19: Is Manaus the final nail in the coffin for natural herd immunity? – The BMJ
Cohort study: Early initiation of prophylactic anticoagulation linked to reduced mortality in patients admitted to hospital with Covid-19
15 Feb, 2021 | 01:18h | UTCCommentaries: Preventive blood thinning drugs could reduce COVID hospital deaths – London School of Hygiene & Tropical Medicine AND Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients – The BMJ AND Expert reaction to a study looking at prophylactic anticoagulants as a treatment for hospitalised patients with COVID-19 – Science Media Centre AND
Commentary on Twitter
Blood thinning drugs are now linked to a reduced risk of death for COVID19 patients. Those given preventive blood thinners (prophylactic anticoagulants) within 24 hours of hospital admission for Covid were less likely to die. New report in the BMJ https://t.co/KQqQ3Zoj8B pic.twitter.com/6wJj8mEucw
— delthia ricks ? (@DelthiaRicks) February 12, 2021
Take whatever COVID vaccine you can get. All of them stop death and hospitalization
15 Feb, 2021 | 01:17h | UTCTake whatever COVID vaccine you can get. All of them stop death and hospitalization – USA Today
“All seven COVID-19 vaccines that have completed large efficacy trials — Pfizer, Moderna, Johnson & Johnson, Novavax, AstraZeneca, Sputnik V and Sinovac — appear to be 100% effective for serious complications. Not one vaccinated person has gotten sick enough to require hospitalization. Not a single vaccinated person has died of COVID-19.”
Small RCT: No effect from Zinc and Vitamin C supplementation among ambulatory patients with SARS-CoV-2 infection
15 Feb, 2021 | 01:20h | UTCCommentaries: Vitamin C, zinc don’t lessen Covid-19 symptoms, study finds – CNN AND Supplements for the Treatment of Mild COVID-19—Challenging Health Beliefs With Science From A to Z – JAMA Network Open AND Zinc, vitamin C show no effect for COVID-19 in small study – CIDRAP AND Expert reaction to a study looking at prophylactic anticoagulants as a treatment for hospitalised patients with COVID-19 – Science Media Centre
Commentary on Twitter
RCT finds high-dose zinc, ascorbic acid (vitamin C), or both, did not significantly decrease the duration of symptoms in ambulatory patients with #COVID19 vs standard of care. @DesaiMilindY @ClevelandClinic @ErinMichos @miguelcainzos23 #VisualAbstract https://t.co/ahcc2awJB8
— JAMA Network Open (@JAMANetworkOpen) February 12, 2021
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
15 Feb, 2021 | 01:14h | UTC
Commentaries on Twitter
NEW—#COVID19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, & successful rollout. This Health Policy compares potential of 26 leading vaccines + vaccine confidence in 32 countries. Read https://t.co/QFeRDHutAi pic.twitter.com/rgknOgCVkg
— The Lancet (@TheLancet) February 12, 2021
The practical issues of #SARSCoV2 vaccines, a new and comprehensive review @TheLancet https://t.co/6sHsac44Ej best current summary of production, $, allocation, deployment, by @ojwouters @LSEHealthPolicy and colleagues pic.twitter.com/mMxOgkjyi0
— Eric Topol (@EricTopol) February 13, 2021